Loading…
HXRefactored 2016 has ended
HXRefactored 2016 Agenda
View analytic
avatar for Aymen Elfiky

Aymen Elfiky

Massive Bio
Co-founder and CMIO

Dr Elfiky maintains an active clinical workload which he leverages with his formal informatics expertise to orchestrate practice and process innovation across the cancer care continuum at Dana-Farber Cancer Institute (DFCI) and Brigham and Women's Hospital (BWH).  At the same time, by utilizing the spectrum of individual and organizational data assets, he works to inform value-based care objectives through critical payment, policy, and practice assessments within the healthcare sector.   

Fundamentally driven by the dedication to patient empowerment and democratization of precision oncology care, as a founding member of the Massive Bio team, Dr. Elfiky works to fill the key knowledge gaps for cancer patients and their treating oncologists.  Through Massive Bio, his focus is demonstrating the ability of technology-enabled care to create and capture shared value and trust for patients and the range of healthcare stakeholders.